290 related articles for article (PubMed ID: 18606142)
1. Neuraminidase 1 is a negative regulator of lysosomal exocytosis.
Yogalingam G; Bonten EJ; van de Vlekkert D; Hu H; Moshiach S; Connell SA; d'Azzo A
Dev Cell; 2008 Jul; 15(1):74-86. PubMed ID: 18606142
[TBL] [Abstract][Full Text] [Related]
2. Lysosomal NEU1 deficiency affects amyloid precursor protein levels and amyloid-β secretion via deregulated lysosomal exocytosis.
Annunziata I; Patterson A; Helton D; Hu H; Moshiach S; Gomero E; Nixon R; d'Azzo A
Nat Commun; 2013; 4():2734. PubMed ID: 24225533
[TBL] [Abstract][Full Text] [Related]
3. Splice donor site mutation in the lysosomal neuraminidase gene causing exon skipping and complete loss of enzyme activity in a sialidosis patient.
Penzel R; Uhl J; Kopitz J; Beck M; Otto HF; Cantz M
FEBS Lett; 2001 Jul; 501(2-3):135-8. PubMed ID: 11470272
[TBL] [Abstract][Full Text] [Related]
4. Lysosomal multienzyme complex: pros and cons of working together.
Bonten EJ; Annunziata I; d'Azzo A
Cell Mol Life Sci; 2014 Jun; 71(11):2017-32. PubMed ID: 24337808
[TBL] [Abstract][Full Text] [Related]
5. Modeling Sialidosis with Neural Precursor Cells Derived from Patient-Derived Induced Pluripotent Stem Cells.
Seol B; Kim YD; Cho YS
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33922276
[TBL] [Abstract][Full Text] [Related]
6. Identification of a CTL4/Neu1 fusion transcript in a sialidosis patient.
Uhl J; Penzel R; Sergi C; Kopitz J; Otto HF; Cantz M
FEBS Lett; 2002 Jun; 521(1-3):19-23. PubMed ID: 12067718
[TBL] [Abstract][Full Text] [Related]
7. Vacuolization and alterations of lysosomal membrane proteins in cochlear marginal cells contribute to hearing loss in neuraminidase 1-deficient mice.
Wu X; Steigelman KA; Bonten E; Hu H; He W; Ren T; Zuo J; d'Azzo A
Biochim Biophys Acta; 2010 Feb; 1802(2):259-68. PubMed ID: 19857571
[TBL] [Abstract][Full Text] [Related]
8. Elimination of abnormal sialylglycoproteins in fibroblasts with sialidosis and galactosialidosis by normal gene transfer and enzyme replacement.
Oheda Y; Kotani M; Murata M; Sakuraba H; Kadota Y; Tatano Y; Kuwahara J; Itoh K
Glycobiology; 2006 Apr; 16(4):271-80. PubMed ID: 16361247
[TBL] [Abstract][Full Text] [Related]
9. Intermittent enzyme replacement therapy with recombinant human β-galactosidase prevents neuraminidase 1 deficiency.
Luu AR; Wong C; Agrawal V; Wise N; Handyside B; Lo MJ; Pacheco G; Felix JB; Giaramita A; d'Azzo A; Vincelette J; Bullens S; Bunting S; Christianson TM; Hague CM; LeBowitz JH; Yogalingam G
J Biol Chem; 2020 Sep; 295(39):13556-13569. PubMed ID: 32727849
[TBL] [Abstract][Full Text] [Related]
10. Lysosomes behave as Ca2+-regulated exocytic vesicles in fibroblasts and epithelial cells.
Rodríguez A; Webster P; Ortego J; Andrews NW
J Cell Biol; 1997 Apr; 137(1):93-104. PubMed ID: 9105039
[TBL] [Abstract][Full Text] [Related]
11. Neu4, a novel human lysosomal lumen sialidase, confers normal phenotype to sialidosis and galactosialidosis cells.
Seyrantepe V; Landry K; Trudel S; Hassan JA; Morales CR; Pshezhetsky AV
J Biol Chem; 2004 Aug; 279(35):37021-9. PubMed ID: 15213228
[TBL] [Abstract][Full Text] [Related]
12. Systemic and neurologic abnormalities distinguish the lysosomal disorders sialidosis and galactosialidosis in mice.
de Geest N; Bonten E; Mann L; de Sousa-Hitzler J; Hahn C; d'Azzo A
Hum Mol Genet; 2002 Jun; 11(12):1455-64. PubMed ID: 12023988
[TBL] [Abstract][Full Text] [Related]
13. Excessive exosome release is the pathogenic pathway linking a lysosomal deficiency to generalized fibrosis.
van de Vlekkert D; Demmers J; Nguyen XX; Campos Y; Machado E; Annunziata I; Hu H; Gomero E; Qiu X; Bongiovanni A; Feghali-Bostwick CA; d'Azzo A
Sci Adv; 2019 Jul; 5(7):eaav3270. PubMed ID: 31328155
[TBL] [Abstract][Full Text] [Related]
14. Biochemical and molecular characterization of novel mutations in GLB1 and NEU1 in patient cells with lysosomal storage disorders.
Kwak JE; Son MY; Son YS; Son MJ; Cho YS
Biochem Biophys Res Commun; 2015 Feb; 457(4):554-60. PubMed ID: 25600812
[TBL] [Abstract][Full Text] [Related]
15. Regulated lysosomal exocytosis mediates cancer progression.
Machado E; White-Gilbertson S; van de Vlekkert D; Janke L; Moshiach S; Campos Y; Finkelstein D; Gomero E; Mosca R; Qiu X; Morton CL; Annunziata I; d'Azzo A
Sci Adv; 2015 Dec; 1(11):e1500603. PubMed ID: 26824057
[TBL] [Abstract][Full Text] [Related]
16. Severe kidney dysfunction in sialidosis mice reveals an essential role for neuraminidase 1 in reabsorption.
Kho I; Demina EP; Pan X; Londono I; Cairo CW; Sturiale L; Palmigiano A; Messina A; Garozzo D; Ung RV; Mac-Way F; Bonneil É; Thibault P; Lemaire M; Morales CR; Pshezhetsky AV
JCI Insight; 2023 Oct; 8(20):. PubMed ID: 37698928
[TBL] [Abstract][Full Text] [Related]
17. Positive regulation of insulin signaling by neuraminidase 1.
Dridi L; Seyrantepe V; Fougerat A; Pan X; Bonneil E; Thibault P; Moreau A; Mitchell GA; Heveker N; Cairo CW; Issad T; Hinek A; Pshezhetsky AV
Diabetes; 2013 Jul; 62(7):2338-46. PubMed ID: 23520133
[TBL] [Abstract][Full Text] [Related]
18. Monocyte differentiation up-regulates the expression of the lysosomal sialidase, Neu1, and triggers its targeting to the plasma membrane via major histocompatibility complex class II-positive compartments.
Liang F; Seyrantepe V; Landry K; Ahmad R; Ahmad A; Stamatos NM; Pshezhetsky AV
J Biol Chem; 2006 Sep; 281(37):27526-38. PubMed ID: 16835219
[TBL] [Abstract][Full Text] [Related]
19. Establishment and characterization of Neu1-knockout zebrafish and its abnormal clinical phenotypes.
Okada K; Takase R; Hamaoka Y; Honda A; Ikeda A; Hokazono Y; Maeda Y; Hayasaka O; Kotani T; Komatsu M; Shiozaki K
Biochem J; 2020 Aug; 477(15):2841-2857. PubMed ID: 32686823
[TBL] [Abstract][Full Text] [Related]
20. β-Glucuronidase, a Regulator of Lyme Arthritis Severity, Modulates Lysosomal Trafficking and MMP-9 Secretion in Response to Inflammatory Stimuli.
Bramwell KK; Mock K; Ma Y; Weis JH; Teuscher C; Weis JJ
J Immunol; 2015 Aug; 195(4):1647-56. PubMed ID: 26170381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
